Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.

CRL

Charles River Laboratories (CRL)

Charles River Laboratories International Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NYSE:CRL
DatumZeitQuelleÜberschriftSymbolFirma
16/05/202422h35Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:CRLCharles River Laboratories International Inc
16/05/202401h30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:CRLCharles River Laboratories International Inc
16/05/202401h24Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:CRLCharles River Laboratories International Inc
15/05/202423h52Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:CRLCharles River Laboratories International Inc
15/05/202423h47Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:CRLCharles River Laboratories International Inc
15/05/202423h42Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:CRLCharles River Laboratories International Inc
15/05/202423h38Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:CRLCharles River Laboratories International Inc
15/05/202423h34Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:CRLCharles River Laboratories International Inc
15/05/202423h30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:CRLCharles River Laboratories International Inc
15/05/202423h27Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:CRLCharles River Laboratories International Inc
15/05/202423h14Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:CRLCharles River Laboratories International Inc
15/05/202422h06Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:CRLCharles River Laboratories International Inc
14/05/202422h49Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:CRLCharles River Laboratories International Inc
10/05/202422h07Edgar (US Regulatory)Form 8-K - Current reportNYSE:CRLCharles River Laboratories International Inc
10/05/202417h30Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:CRLCharles River Laboratories International Inc
09/05/202422h20Edgar (US Regulatory)Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuersNYSE:CRLCharles River Laboratories International Inc
09/05/202415h17Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NYSE:CRLCharles River Laboratories International Inc
09/05/202413h31Edgar (US Regulatory)Form 8-K - Current reportNYSE:CRLCharles River Laboratories International Inc
09/05/202413h00Business WireCharles River Laboratories Announces First-Quarter 2024 ResultsNYSE:CRLCharles River Laboratories International Inc
02/05/202414h00Business WireCharles River Launches Viral Vector Reference Materials to Streamline the Transition to GMPNYSE:CRLCharles River Laboratories International Inc
22/04/202414h00Business WireCharles River Laboratories Achieves 100% Renewable Electricity Usage GloballyNYSE:CRLCharles River Laboratories International Inc
16/04/202414h00Business WireCharles River Laboratories Launches Alternative Methods Advancement Project to Reduce Reliance on Animal TestingNYSE:CRLCharles River Laboratories International Inc
12/04/202414h00Business WireCharles River Laboratories Schedules First-Quarter 2024 Earnings Release and Conference CallNYSE:CRLCharles River Laboratories International Inc
11/04/202414h00Business WireCharles River and Deciphex Launch Patholytix Foresight, a Transformative AI-Powered Decision Support Tool for Toxicologic PathologyNYSE:CRLCharles River Laboratories International Inc
09/04/202414h00Business WireCharles River Announces Rare Disease Gene Therapy Collaboration with Axovia TherapeuticsNYSE:CRLCharles River Laboratories International Inc
04/04/202414h00Business WireCharles River to Perform Plasmid Production for Ship of TheseusNYSE:CRLCharles River Laboratories International Inc
04/04/202414h00Business WireCharles River to Perform Plasmid Production for Ship of TheseusNYSE:CRLCharles River Laboratories International Inc
01/04/202414h00Business WireCharles River Laboratories Showcases Technology-Driven Capabilities at AACR 2024NYSE:CRLCharles River Laboratories International Inc
27/03/202413h00Business WireCharles River Laboratories Publishes 2023 Corporate Citizenship ReportNYSE:CRLCharles River Laboratories International Inc
21/03/202413h00Business WireCharles River Announces Extension of Gene Therapy Manufacturing Alliance with NUS Yong Loo Lin School of MedicineNYSE:CRLCharles River Laboratories International Inc
 Showing the most relevant articles for your search:NYSE:CRL